Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (171-180 of 667) with videos related to

Pageof 67
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|February 22, 2023
Lutetium Lu 177 vipivotide tetraxetan for prostate cancerXing Liu, Gao-Chuan Fang, Hao Lu, et al.
Molecular Medicine (Cambridge, Mass.)|November 11, 2024
PI3K p85α/HIF-1α accelerates the development of pulmonary arterial hypertension by regulating fatty acid uptake and mitophagyChenyang Chen, Sirun Qin, Xiaohua Song, et al.
Frontiers in Pharmacology|August 14, 2023
Darovasertib, a novel treatment for metastatic uveal melanomaLei Cao, Shuzhen Chen, Rainie Sun, et al.
Cancer Genetics|May 27, 2026
TFRC-mediated immune exclusion as a therapeutic vulnerability in cervical cancer: A comprehensive analysis based on the cancer immunoediting processHong-Jian Ling, Jia-Li Zhou, Lu-Qi Cao, et al.
Journal of Biomedical Research|September 4, 2018
Design, synthesis and biological evaluation of selective survivin inhibitorsMin Xiao, Yi Xue, Zhongzhi Wu, et al.
Frontiers in Oncology|March 11, 2021
Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell LineZhuo-Xun Wu, Yuqi Yang, Leli Zeng, et al.
Molecular Pharmacology|January 16, 2003
Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10)Zhe-Sheng Chen, Elizabeth Hopper-Borge, Martin G Belinsky, et al.
Anti-Cancer Drugs|August 21, 2007
Reversal effect of BM-cyclin 1 on multidrug resistance in C-A120 cellsLin Wang, Jian Sun, Yong-Qiang Li, et al.
Nano Letters|October 22, 2021
Manipulating Nanowire Assemblies toward Multicolor Transparent Electrochromic DeviceJin-Long Wang, Jian-Wei Liu, Si-Zhe Sheng, et al.
International Journal of Oncology|February 23, 2024
HER2<sup>+</sup> advanced gastric cancer: Current state and opportunities (Review)Hui-Hui Hu, Sai-Qi Wang, Huichen Zhao, et al.
Pageof 67

Showing results (171-180 of 667) with videos related to

Sort By:
Pageof 67
Drugs of Today (Barcelona, Spain : 1998)|February 22, 2023
Lutetium Lu 177 vipivotide tetraxetan for prostate cancerXing Liu, Gao-Chuan Fang, Hao Lu, et al.
Molecular Medicine (Cambridge, Mass.)|November 11, 2024
PI3K p85α/HIF-1α accelerates the development of pulmonary arterial hypertension by regulating fatty acid uptake and mitophagyChenyang Chen, Sirun Qin, Xiaohua Song, et al.
Frontiers in Pharmacology|August 14, 2023
Darovasertib, a novel treatment for metastatic uveal melanomaLei Cao, Shuzhen Chen, Rainie Sun, et al.
Cancer Genetics|May 27, 2026
TFRC-mediated immune exclusion as a therapeutic vulnerability in cervical cancer: A comprehensive analysis based on the cancer immunoediting processHong-Jian Ling, Jia-Li Zhou, Lu-Qi Cao, et al.
Journal of Biomedical Research|September 4, 2018
Design, synthesis and biological evaluation of selective survivin inhibitorsMin Xiao, Yi Xue, Zhongzhi Wu, et al.
Frontiers in Oncology|March 11, 2021
Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell LineZhuo-Xun Wu, Yuqi Yang, Leli Zeng, et al.
Molecular Pharmacology|January 16, 2003
Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10)Zhe-Sheng Chen, Elizabeth Hopper-Borge, Martin G Belinsky, et al.
Anti-Cancer Drugs|August 21, 2007
Reversal effect of BM-cyclin 1 on multidrug resistance in C-A120 cellsLin Wang, Jian Sun, Yong-Qiang Li, et al.
Nano Letters|October 22, 2021
Manipulating Nanowire Assemblies toward Multicolor Transparent Electrochromic DeviceJin-Long Wang, Jian-Wei Liu, Si-Zhe Sheng, et al.
International Journal of Oncology|February 23, 2024
HER2<sup>+</sup> advanced gastric cancer: Current state and opportunities (Review)Hui-Hui Hu, Sai-Qi Wang, Huichen Zhao, et al.
Pageof 67